Trial · NCT03800875
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Total percentage of time (22:00-22:00) that the glucose concentration remained within 3.9 and 10.0 mmol/L | 24 hours | |
| Secondary | Total percentage of time (22:00-22:00) that the glucose concentration remained within specified ranges. | 24 hours | a. between 3.9 and 7.8 mmol/L; b. below 3.9 mmol/L; c. between 3.9 and 10 mmol/L d. below 3.3 mmol/L; e. below 2.8 mmol/L; f. above 7.8 mmol/L; g. above 10 mmol/L; h. above 13.9 mmol/L; i. above 16.7 mmol/L. |
| Secondary | Percentage of overnight time (24:00-8:00) that the glucose concentration remained within specified ranges. | 8 hours | a. between 3.9 and 7.8 mmol/L; b. between 3.9 and 10 mmol/L; c. below 3.9 mmol/L; d. below 3.3 mmol/L; e. below 2.8 mmol/L; f. above 7.8 mmol/L; g. above 10 mmol/L; h. above 13.9 mmol/L; i. above 16.7 mmol/L. |
| Secondary | Total amount of insulin delivered to the participant | 24 hours | |
| Secondary | Mean sensor glucose concentration during the overnight stay | 8 hours | |
| Secondary | Number of participants experiencing hypoglycemia requiring oral treatment during: a. the overall study period; b. the night; c. the day | 27 hours | |
| Secondary | The number and severity of gastrointestinal sysmptoms experienced by a participant | 27 hours | GI symptoms include: nausea, vomiting, bloating and heartburn |
| Secondary | Mean daytime insulin concentration | 14 hours | |
| Secondary | Mean daytime concentration of amylin | 14 hours | |
| Secondary | Total amount of pramlintide delivered to the participant | 24 hours | |
| Secondary | Mean glucose level | 24-hour period |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03800875/registered